Agnes Zong

Agnes Zong is a Senior Scientist at Janux Therapeutics since January 2024, with prior experience as a Scientist at Turnstone Biologics and Fate Therapeutics Inc., and as a Graduate Research Assistant at Indiana University Bloomington. Zong has extensive expertise in identifying cancer stem cell populations through flow cytometry, proficient in gene editing with the CRISPR/Cas9 system, and lentiviral transduction. Zong's earlier roles include a translational research internship at AbbVie and undergraduate research at China Medical University, focusing on microRNA-100's role in breast cancer and developing drug delivery systems. Agnes Zong holds a PhD in Pharmacology from Indiana University Bloomington and a BS in Clinical Pharmacy from China Medical University.